13 May 2024 MAYNE PHARMA ANNOUNCES GRANT OF TWO ADDITIONAL PATENTS FOR NEXTSTELLIS® ORAL CONTRACEPTIVE 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post